A detailed history of Red Tortoise LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Red Tortoise LLC holds 138 shares of BMY stock, worth $8,111. This represents 0.0% of its overall portfolio holdings.

Number of Shares
138
Previous 538 74.35%
Holding current value
$8,111
Previous $22,000 68.18%
% of portfolio
0.0%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$39.66 - $51.75 $15,863 - $20,700
-400 Reduced 74.35%
138 $7,000
Q2 2024

Jul 31, 2024

BUY
$40.25 - $52.99 $14,651 - $19,288
364 Added 209.2%
538 $22,000
Q1 2024

Apr 19, 2024

BUY
$47.98 - $54.4 $8,348 - $9,465
174 New
174 $9,000
Q3 2023

Nov 02, 2023

BUY
$57.89 - $64.73 $20,145 - $22,526
348 New
348 $20,000
Q1 2023

May 16, 2023

SELL
$65.71 - $74.53 $4,336 - $4,918
-66 Reduced 36.26%
116 $8,000
Q4 2022

Feb 01, 2023

BUY
$68.48 - $81.09 $12,463 - $14,758
182 New
182 $13,000
Q3 2021

Nov 07, 2022

BUY
$59.17 - $69.31 $9,644 - $11,297
163 New
163 $12,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Red Tortoise LLC Portfolio

Follow Red Tortoise LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Tortoise LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Tortoise LLC with notifications on news.